HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 44 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $24,000 | -53.8% | 72,858 | +0.0% | 0.01% | -50.0% |
| Q2 2020 | $52,000 | +116.7% | 72,850 | +0.0% | 0.02% | +100.0% |
| Q1 2020 | $24,000 | -50.0% | 72,849 | +8.9% | 0.01% | -35.3% |
| Q4 2019 | $48,000 | +4.3% | 66,900 | 0.0% | 0.02% | -5.6% |
| Q3 2019 | $46,000 | -58.6% | 66,900 | 0.0% | 0.02% | -64.0% |
| Q2 2019 | $111,000 | -30.2% | 66,900 | +5.0% | 0.05% | -51.5% |
| Q1 2019 | $159,000 | -11.2% | 63,724 | -14.4% | 0.10% | +18.4% |
| Q4 2018 | $179,000 | -41.9% | 74,420 | +6.5% | 0.09% | -47.3% |
| Q3 2018 | $308,000 | +124.8% | 69,900 | +83.9% | 0.16% | +166.1% |
| Q2 2018 | $137,000 | -50.0% | 38,000 | -50.0% | 0.06% | -23.5% |
| Q1 2018 | $274,000 | – | 76,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 2,426,300 | $802,000 | 0.74% |
| Cowen Prime Services LLC | 1,411,500 | $466,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 1,205,873 | $398,000 | 0.07% |
| Nantahala Capital Management | 5,113,958 | $1,690,000 | 0.05% |
| HighMark Wealth Management LLC | 80,000 | $26,000 | 0.02% |
| Kalos Management, Inc. | 72,858 | $24,000 | 0.01% |
| Qube Research & Technologies Ltd | 585,187 | $193,000 | 0.00% |
| WINTON GROUP Ltd | 190,146 | $63,000 | 0.00% |
| Ironwood Financial, llc | 1,571 | $1,000 | 0.00% |
| Virtu Financial LLC | 12,049 | $4,000 | 0.00% |